aibioAura Biosciences holders approve raising authorized shares to 500,000,000
Tickers AURA
Authorized common shares rise from 150,000,000. The August 5, 2026 special meeting also approved an amendment to the 2021 Stock Option and Incentive Plan.
Key facts
- Company
- Aura Biosciences, Inc. (NASDAQ: AURA)
- News type
- Listings
- Primary source
- Aura Biosciences, Inc. 8-K (2026-08-05)
Aura Biosciences, Inc. (Nasdaq: AURA) held a Special Meeting of Stockholders on August 5, 2026. Stockholders approved an amendment to the company's Tenth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 500,000,000.
The proposal passed with 62,993,701 votes for, 26,496,186 against and 839 abstentions. There were no broker non-votes.
Stockholders also approved Amendment No. 1 to the 2021 Stock Option and Incentive Plan. That vote was 46,369,676 for, 27,372,773 against, 819 abstentions and 15,747,458 broker non-votes.
As of June 12, 2026, the record date, 103,436,416 shares of common stock were outstanding and entitled to vote. A total of 89,490,726 shares were represented in person or by proxy, which made a quorum.
The company filed its Definitive Proxy Statement on Schedule 14A on June 29, 2026. No other matters were submitted to a vote.